Microsporidiosis epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2] Ahmed Younes M.B.B.CH [3]
Overview
Overview
The overall prevalence is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in immunocompromised patients with correlating gastrointestinal tract symptoms to microsporidiosis). The disease is present all over the world. In HIV patients with diarrhea, the prevalence of microsporidiosis was 39% being the most common isolated organism.
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence:
- The overall prevalence is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in immunocompromised patients with correlating gastrointestinal tract symptoms to microsporidiosis).[1][2]
- In HIV patients with diarrhea, the prevalence of microsporidiosis was 39% being the most common isolated organism.
Case fatality rate:
- The case-fatality rate of intestinal microsporidiosis is approximately 56% among HIV patients.
Race
- There is no racial predilection to the microsporidiosis.[3]
Age
- Patients of all age groups may develop microsporidiosis.[3]
Sex
- Males and females are affected equally by microsporidiosis.[3]
Geographic distribution
- Microsporidiosis infections occur worldwide with no geographic predilection.[2]
References
References
- ↑ Kotler DP, Orenstein JM (1994). “Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation”. Am. J. Gastroenterol. 89 (11): 1998–2002. PMID 7942725.
- ↑ 2.0 2.1 “CDC – DPDx – Microsporidiosis”.
- ↑ 3.0 3.1 3.2 Didier ES, Weiss LM (2006). “Microsporidiosis: current status”. Curr Opin Infect Dis. 19 (5): 485–92. doi:10.1097/01.qco.0000244055.46382.23. PMC 3109650. PMID 16940873.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH